ENvue Medical Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. The company's product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary cathet… Read more
Market Cap & Net Worth: ENvue Medical Inc. (FEED)
ENvue Medical Inc. (NASDAQ:FEED) has a market capitalization of $13.75K ($13.75K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #44411 globally and #14084 in its home market, demonstrating a -23.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ENvue Medical Inc.'s stock price $1.47 by its total outstanding shares 9356 (9.36K).
ENvue Medical Inc. Market Cap History: 2026 to 2026
ENvue Medical Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $13.75K to $13.75K (0.00% CAGR).
ENvue Medical Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ENvue Medical Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of FEED by Market Capitalization
Companies near ENvue Medical Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to ENvue Medical Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
ENvue Medical Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, ENvue Medical Inc.'s market cap moved from $13.75K to $ 13.75K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.75K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ENvue Medical Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.75K USD |
| MoneyControl | $13.75K USD |
| MarketWatch | $13.75K USD |
| marketcap.company | $13.75K USD |
| Reuters | $13.75K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.